Guo L - Search Results

1

The effects of jaspamide on human cardiomyocyte function and cardiac ion channel activity.

Schweikart K, Guo L, Shuler Z, Abrams R, Chiao ET, Kolaja KL, Davis M. Schweikart K, et al. Among authors: guo l. Toxicol In Vitro. 2013 Mar;27(2):745-51. doi: 10.1016/j.tiv.2012.12.005. Epub 2012 Dec 20. Toxicol In Vitro. 2013. PMID: 23261645 Free PMC article.

2

The electrophysiological effects of cardiac glycosides in human iPSC-derived cardiomyocytes and in guinea pig isolated hearts.

Guo L, Qian JY, Abrams R, Tang HM, Weiser T, Sanders MJ, Kolaja KL. Guo L, et al. Cell Physiol Biochem. 2011;27(5):453-62. doi: 10.1159/000329966. Epub 2011 Jun 15. Cell Physiol Biochem. 2011. PMID: 21691062

3

Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes.

Guo L, Abrams RM, Babiarz JE, Cohen JD, Kameoka S, Sanders MJ, Chiao E, Kolaja KL. Guo L, et al. Toxicol Sci. 2011 Sep;123(1):281-9. doi: 10.1093/toxsci/kfr158. Epub 2011 Jun 20. Toxicol Sci. 2011. PMID: 21693436

4

Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model.

Guo L, Coyle L, Abrams RM, Kemper R, Chiao ET, Kolaja KL. Guo L, et al. Toxicol Sci. 2013 Dec;136(2):581-94. doi: 10.1093/toxsci/kft205. Epub 2013 Sep 19. Toxicol Sci. 2013. PMID: 24052561

5

Human stem cell-derived cardiomyocytes in cellular impedance assays: bringing cardiotoxicity screening to the front line.

Peters MF, Lamore SD, Guo L, Scott CW, Kolaja KL. Peters MF, et al. Among authors: guo l. Cardiovasc Toxicol. 2015 Apr;15(2):127-39. doi: 10.1007/s12012-014-9268-9. Cardiovasc Toxicol. 2015. PMID: 25134468 Review.

6

Human CD34(+) progenitor hematopoiesis in liquid culture for in vitro assessment of drug-induced myelotoxicity.

Guo L, Hamre J 3rd, Davis M, Parchment RE. Guo L, et al. Toxicol In Vitro. 2016 Mar;31:103-13. doi: 10.1016/j.tiv.2015.11.017. Epub 2015 Nov 23. Toxicol In Vitro. 2016. PMID: 26616282

7

Role of Mcl-1 in regulation of cell death in human induced pluripotent stem cell-derived cardiomyocytes in vitro.

Guo L, Eldridge S, Furniss M, Mussio J, Davis M. Guo L, et al. Toxicol Appl Pharmacol. 2018 Dec 1;360:88-98. doi: 10.1016/j.taap.2018.09.041. Epub 2018 Sep 28. Toxicol Appl Pharmacol. 2018. PMID: 30268579

8

Use of human stem cell derived cardiomyocytes to examine sunitinib mediated cardiotoxicity and electrophysiological alterations.

Cohen JD, Babiarz JE, Abrams RM, Guo L, Kameoka S, Chiao E, Taunton J, Kolaja KL. Cohen JD, et al. Among authors: guo l. Toxicol Appl Pharmacol. 2011 Nov 15;257(1):74-83. doi: 10.1016/j.taap.2011.08.020. Epub 2011 Aug 27. Toxicol Appl Pharmacol. 2011. PMID: 21906609 Free PMC article.

9

Examining the protective role of ErbB2 modulation in human-induced pluripotent stem cell-derived cardiomyocytes.

Eldridge S, Guo L, Mussio J, Furniss M, Hamre J 3rd, Davis M. Eldridge S, et al. Among authors: guo l. Toxicol Sci. 2014 Oct;141(2):547-59. doi: 10.1093/toxsci/kfu150. Epub 2014 Jul 23. Toxicol Sci. 2014. PMID: 25055963 Free PMC article.

10

Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) to Monitor Compound Effects on Cardiac Myocyte Signaling Pathways.

Guo L, Eldridge S, Furniss M, Mussio J, Davis M. Guo L, et al. Curr Protoc Chem Biol. 2015 Sep 1;7(3):141-185. doi: 10.1002/9780470559277.ch150035. Curr Protoc Chem Biol. 2015. PMID: 26331525 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,860 results

Search Page

Filters